BACCX
Price
$12.96
Change
+$0.09 (+0.70%)
Updated
Oct 17 closing price
Net Assets
264.47M
FANIX
Price
$49.01
Change
+$0.20 (+0.41%)
Updated
Oct 17 closing price
Net Assets
944.33M
Interact to see
Advertisement

BACCX vs FANIX

Header iconBACCX vs FANIX Comparison
Open Charts BACCX vs FANIXBanner chart's image
BlackRock Energy Opportunities Inv C
Price$12.96
Change+$0.09 (+0.70%)
VolumeN/A
Net Assets264.47M
Fidelity Advisor Energy I
Price$49.01
Change+$0.20 (+0.41%)
VolumeN/A
Net Assets944.33M
BACCX vs FANIX Comparison Chart in %
View a ticker or compare two or three
VS
BACCX vs. FANIX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BACCX is a StrongBuy and FANIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FANIX has more cash in the bank: 944M vs. BACCX (264M). BACCX pays higher dividends than FANIX: BACCX (1.66) vs FANIX (0.90). BACCX was incepted earlier than FANIX: BACCX (21 years) vs FANIX (30 years). BACCX (2.10) is less costly to investors than FANIX (0.71). BACCX is a more actively managed with annual turnover of: 66.00 vs. FANIX (15.00). FANIX has a lower initial minimum investment than BACCX: FANIX (0) vs BACCX (1000). FANIX annual gain was more profitable for investors over the last year : 0.82 vs. BACCX (-0.13). FANIX return over 5 years is better than : 258.37 vs. BACCX (179.18).
BACCXFANIXBACCX / FANIX
Total Expense Ratio2.040.71287%
Annual Report Gross Expense Ratio2.100.71296%
Fund Existence21 years30 years-
Gain YTD4.8875.01497%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets264M944M28%
Annual Yield % from dividends1.660.90184%
Returns for 1 year-0.130.82-16%
Returns for 3 years18.6017.71105%
Returns for 5 years179.18258.3769%
Returns for 10 years46.9367.6069%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOA5.180.07
+1.37%
BioAge Labs Inc.
AQST7.080.07
+1.00%
Aquestive Therapeutics
ED101.190.12
+0.12%
Consolidated Edison
FG28.99-0.04
-0.14%
F&G Annuities & Life
CRIS1.54-0.02
-1.28%
Curis